valerie d acremont

51
Epidemiology and Public Health Diagnostic parasitologique des accès palustres: acquis et défis Valérie D‘Acremont, MD, PhD Atelier paludisme Madagascar, 22 Mars 2011

Upload: institut-pasteur-de-madagascar

Post on 21-Nov-2014

438 views

Category:

Health & Medicine


2 download

DESCRIPTION

Conférence de la 8ème édition du Cours international « Atelier Paludisme »

TRANSCRIPT

Page 1: Valerie d acremont

Epidemiology and Public Health

Diagnostic parasitologique des accès

palustres: acquis et défis

Valérie D‘Acremont, MD, PhD

Atelier paludisme Madagascar, 22 Mars 2011

Page 2: Valerie d acremont

How to deal with malaria in patients?

Prompt treatment

Suspected malaria

Early and accurate diagnosis

Page 3: Valerie d acremont

What is ‘malaria’?

Different definitions depending on the purpose:

1) For epidemiological analysis (malaria infection)

� quantify burden of malaria, modelling...

2) For clinical management (malaria disease)

� to decide who should be treated for an

episode of malaria

Definitions of malaria

Page 4: Valerie d acremont

What is a true malaria episode (= illness) ?

CoughDiarrhea

ArthralgiaHeadache

General

population

Sick population

Febrile patients

‘Clinical malaria’

Page 5: Valerie d acremont

What is a true malaria episode (= illness) ?

General

population

Sick population

Febrile patients

Parasites in blood

‘Clinical malaria’

Page 6: Valerie d acremont

What is a true malaria episode (= illness) ?

‘Clinical malaria’

‘Malaria episode’

General

population

Febrile patients

Sick population

Parasites in blood

Page 7: Valerie d acremont

What is a true malaria episode (= illness) ?

CoughDiarrhea

ArthralgiaHeadache

Sick population

General

population

Parasites in blood

Sick people withincidental parasitemia

Page 8: Valerie d acremont

What is a true malaria episode (= illness) ?

‘Clinical malaria’

‘Malaria episode’

General

population

Febrile patients

Sick population

Sick people withincidental parasitemia

OVERDIAGNOSIS

Page 9: Valerie d acremont

What is a true malaria episode (= illness) ?

‘Malaria episode’

General

population

Febrile patients

Sick population

HEALTH FACILITIES:

Only patients that

should be treated !

Parasites in blood

Page 10: Valerie d acremont

In the context of elimination ?

General

population

Parasitemia in healthy people

Sick population

Febrile patients

Parasites in blood

POPULATION SURVEYS:

Treatment of the

hidden reservoir

Page 11: Valerie d acremont

Magnitude of overdiagnosis

Systematic review of 39 studies performed between 1986 and 2007

in 16 African countries including 42,979 patients

Proportion of feversassociated with Pf (%)

0

10

20

30

40

50

60

70

80

90

100

<2000 >2000

44%

22%

D’Acremont, CID 2010

Page 12: Valerie d acremont

Systematic review

Proportion of malaria among fevers in children < 5 years

81%1986Tanzania (rural)

5%2003Dar es Salaam

57%1995

38%1997

21%2005

4%2004Highlands

urbanruralYearCountry

Rooth, Font, Nsimba, Reyburn, Wang

Page 13: Valerie d acremont

Systematic review

Studies providing stratified values of PFPf

by age groups, including older children:

<5 years MEDIAN PR = 27% (IQR 20-50%)

5-14 years MEDIAN PR = 40% (IQR 22-48%)

>15 years MEDIAN PR = 24% (IQR 11-27%)

Page 14: Valerie d acremont

Consequences of over-treatment

Drugs wastage

Left untreatedfor real cause

Reattendances

Costs for patient

Parasite resistanceMistrust

in ACT

Page 15: Valerie d acremont

Predictors for malaria:

Clinical diagnosis: impossible to rely on it

0

Proportion of malaria

among fevers

Drug wastage (overdiagnosis)

20% 40% 60% 80% 100%

20%

40%

60%

80%

100%

Failure to treat (missed cases)

Reviewed by

Chandramohan et al

in 2002

high temperature of short duration

, absence of abdominal pain, absence of rash

, absence of cough

splenomegaly

Page 16: Valerie d acremont

How to deal with malaria in patients?

Prompt treatment

Suspected malaria

Early and accurate diagnosisLAB TEST

Page 17: Valerie d acremont

How to get universal access to

parasitological diagnosis?

Page 18: Valerie d acremont

Available malaria tests: microscopy

Page 19: Valerie d acremont

REGIONAL COURSE ON TRAINING OF TRAINERS ON USE OF

MALARIA RAPID DIAGNOSTIC TESTS (RDTS)

Components of good microscopy performance

Competency

Selection

Training

Assessment

Equipment/

reagents

Support networkSlide /results delivery

Work

environment

Performance

Supervisione.g. cross-checking??

Page 20: Valerie d acremont

Performance of Microscopy for malaria in DSM

Sensitivity = how sensitive is the test to detect the true positive cases

Specificity = how specific is the test to detect the true negative cases

Total

Total

Negative

Positive

Routine microscopy

NegativePositive

Expert microscopy

Sensitivity

= 70%

Specificity

= 45%

328322

148

173

2

5

7

178

150

Page 21: Valerie d acremont

0

20

40

60

80

100

120

140

0 -<

1010

-<10

010

0 -<

1000

1'00

0 -<

10'0

00

10'0

00 -<

100'

000

>100'

000

Reported parasitemia: routine versus expert

Real positives…

Routine microscopy

Expert microscopy

Parasitemia (parasites/µl)

Number of slides

hospitals 41%

health cent. 49%

dispensaries 65%

(range 13-90%)

Page 22: Valerie d acremont

Performance of Microscopy for malaria in

other places

In some places, problem of sensitivity

� cases missed:

71% in Moshi Reyburn et al, 2007

But more often, bad specificity

� overdiagnosis:

62% in Kenya Zurovac et al, 2006

Page 23: Valerie d acremont

Consequences of suboptimal

microscopy for malaria

1) Clinicians do not trust microscopy � overtreatment

Kenya, 2002:

- blood slide performed in 79% of febrile patients

and in 51% of afebrile patients

- 43% (routine) versus 13% (expert) positive slides

- 96% of positive and 79% of negative malaria patients

received treatmentZurovac et al, 2006

Page 24: Valerie d acremont

High mortality among patients admitted to hospital and incorrectly treated for

malaria, 10 hospitals, NE Tanzania

Admissions for malaria n=17,313Admissions for malaria n=17,313

Severe disease n=4670 (27%)Severe disease n=4670 (27%)

Readable slide results n=4474 (95%)Readable slide results n=4474 (95%)

No criteria forsevere disease n=12,643 (73%)120 deaths (1%)

No criteria forsevere disease n=12,643 (73%)120 deaths (1%)

Expert microscopy negativen=2412 (54%)

Expert microscopy negativen=2412 (54%)

Deadn=142 (7%)

Deadn=142 (7%)

Aliven=1920 (93%)

Aliven=1920 (93%)

Deadn=292 (12%)

Deadn=292 (12%)

Aliven=2120 (88%)

Aliven=2120 (88%)

Expert microscopy positiven=2062 (46%)

Expert microscopy positiven=2062 (46%)

Reyburn H et al. BMJ 2006

2) Clinicians tend to ignore non-malarial fevers

Page 25: Valerie d acremont

High mortality among patients admitted to hospital and incorrectly treated for

malaria, 10 hospitals, NE Tanzania

Admissions for malaria n=17,313Admissions for malaria n=17,313

Severe disease n=4670 (27%)Severe disease n=4670 (27%)

Readable slide results n=4474 (95%)Readable slide results n=4474 (95%)

No criteria forsevere disease n=12,643 (73%)120 deaths (1%)

No criteria forsevere disease n=12,643 (73%)120 deaths (1%)

Expert microscopy negativen=2412 (54%)

Expert microscopy negativen=2412 (54%)

Deadn=142 (7%)

Deadn=142 (7%)

Aliven=1920 (93%)

Aliven=1920 (93%)

Deadn=292 (12%)

Deadn=292 (12%)

Aliven=2120 (88%)

Aliven=2120 (88%)

Expert microscopy positiven=2062 (46%)

Expert microscopy positiven=2062 (46%)

Reyburn H et al. BMJ 2006

2) Clinicians tend to ignore non-malarial fevers

Dar es Salaam (Muhimbili hospital)

‘cerebral malaria’

22% in slide negative patients13% in slide positive patients

Makani et al 2003

Page 26: Valerie d acremont

A reliable test available at time and place of need,

used for more than 15 years in Europe

and 7 years in South Africa...

Add another malaria diagnostic test

Page 27: Valerie d acremont

Meta-analysis published in 2006:

HRP2 RDT at least as sensitiveas expert microscopy

REF: Ochola Lancet Infect Dis 2006

100%

90

80

70

60

50

40

30

20

10

0

Microscopy

HRP2 RDT

pLDH RDT

QBCAO

Sensitivity in the absence of a gold standard

Relative performance of each method

Page 28: Valerie d acremont

Technologies evolve quickly :

REF: Bell AJTMH 2005 Dal-Bianco AJTMH 2007 Stauffer CID 2009

Stauffer 2009

Dal-Bianco2007

Bell 2005

Author, year

SensitivityProportion

RDT(+) / BS(-)

positives by PCR

88%100%60%Travelers USA

22%46%80%Gabon

70%?91%92%Philippines

MicroscopyRDT

Origin of the samples

Conclusion: between 60 and 90% of so-called false-positive RDT

are real positives, reflecting the high sensitivity of HRP2 RDT

Relative performance of each method

Page 29: Valerie d acremont

Putative explanation for greater sensitivity of a RDT

relying on detection of a persistent antigen

REF: Bell AJTMH 2005

Relative performance of each method

Page 30: Valerie d acremont

Objective

To evaluate in an uncontrolled setting the

safety (clinical outcome) of withholding antimalarials

in febrile children with a negative RDT

in a moderately endemic area (urban setting)

in a highly endemic area (rural setting)

Safety study of RDT in Tanzania

Page 31: Valerie d acremont

1000

febrile children

603 (60%) RDTm -ve

396

followed up

591 followed up

387 (98%)

cured573 (97%)

cured

18 (3%)

still sick

15 RDTm -ve

2 RDTm still +ve

1 still no RDTm

1 LOF 12 LOF

2 LOF

2 RDT -ve

9 (2%)

still sick

BS negative

8 cured

1 LOF

1 admitted

2 deceased2 RDTm&BS -ve

14

cured

1 admitted1 RDTm&BS -ve

Day

0 D

ay

7 >

Da

y14

397 (40%) RDTm +ve

Page 32: Valerie d acremont

Translation of research findings into policy

Translation of research findings into policy

Page 33: Valerie d acremont

Improve laboratory diagnosis for malaria

in routine management of fever cases at

OPD

Implementation of RDT in Dar es Salaam

Intervention:

Pilot implementation

of RDT in Dar es Salaam

in the 3 district hospitals,

3 health centres

and 3 dispensaries

Page 34: Valerie d acremont

Methodology

Consultation process:

Baseline survey9 Intervention HF

Consultation process:

Post-intervention survey9 Intervention HF

INTERVENTIONTraining, RDTm implementation, quaterly supervision

3. Routine statistics of Health Facilities

Consultation process:3 Control HF

Consultation process:

3 Control HF

2. Cluster randomizedstudy

1. Before and afterstudy

2007 20082006

Page 35: Valerie d acremont

1. Before-after cluster randomized study

Patients with history of fever

Proportions of patients treated with antimalarials

9 intervention HF

BEFORE AFTER

3 control HF

81%

24%

65%

Page 36: Valerie d acremont

0%

20%

40%

60%

80%

100%

Ja

n

Fe

b

Ma

r

Ap

r

Ma

y

Ju

n

Ju

l

Au

g

Se

p

Oc

t

No

v

De

c

Ja

n

Fe

b

Ma

r

Ap

r

Ma

y

Ju

n

Ju

l

Au

g

Se

p

Oc

t

No

v

De

c

Ja

n

Fe

b

Ma

r

Ap

r

Ma

y

Ju

n

Ju

l

Au

g

Se

p

Po

sit

ivit

y r

ate

1) Performance of routine mRDT much better than

routine microscopy

� better specificity � less overdiagnosis

mRDT implementation

2006 2007 2008

Routine microscopy48%

Routine RDT8%

Results 1: why did it work?

Page 37: Valerie d acremont

2) Negative RDT patients are not treated for malaria

more trust in mRDT � better adherence to the guidelines

Negative patients treated

With microscopy With mRDT

53%

7%

Results 1: why did it work?

Page 38: Valerie d acremont

0

5000

10000

15000

20000

25000Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

dispensary 3

dispensary 2

dispensary 1

health centre 3

health centre 2

health centre 1

hospital 3

hospital 2

hospital 1

mRDT

2007 2008

Results 2: longitudinal study

Artemether/lumefantrine (ALu)

Page 39: Valerie d acremont

0

2000

4000

6000

8000

10000

12000

14000

16000

18000

Jan

Mar

May

Jul

Sep

Nov

Jan

Mar

May

Jul

Sep

Nov

Jan

Mar

May

Jul

Sep

dispensary 3

dispensary 2

dispensary 1

health centre 3

health centre 2

health centre 1

hospital 3

hospital 2

hospital 1

mRDT

2007 20082006

Quinine vials

Results 2: longitudinal study

Page 40: Valerie d acremont

Severe malaria

Give i.v quinine

Severe illness (NOT malaria)

• STOP antimalarials

• Continue with appropriate antibiotic

• Investigate for other causes of fever

• Repeat RDT and BS after 12-24hrs

Admission

Give immediately antimalarial and antibiotic

DANGER SIGNS

Perform RDT or BS

Uncomplicated malaria

Give antimalarial

Febrile illness(NOT malaria)

• Do NOT give

antimalarial

• Invest. for other

causes of fever

Do NOT

perform a

malaria test

NO

YES

NO

YES

Perform BS

+/- RDT

BS and RDT both

negatives

RDT and/or

BS positive

positive negative

Follow-up

PRIMARY AND SECONDARY LEVELPRIMARY LEVEL SECONDARY LEVEL

Refer the

patient

immediately

High malaria risk area

FEVER ANEMIA

Low malaria risk area

FEVER without an

obvious cause of fever ?

Suspected malaria case

NO

Page 41: Valerie d acremont

Antibiotic prescriptions in Dar es Salaam

Antibiotics

Antimalarials

� Proportion of febrile patients receiving:

D’Acremont et al, 2010, submitted

Before RDT implementation

After RDT implementation

49% 73%

81% 24%

Page 42: Valerie d acremont

But what are the causes of all these fevers

that are not malaria ?

?

8%

Study on etiologies of fever in children

Page 43: Valerie d acremont

To determine the etiology of fever

episodes in small children living in urban

and rural Tanzania

children 2 months - 10 yrs

temperature > 38°C

Methodology of the fever study

1005 patients

(507 in Dar es Salaam

and 498 in Ifakara)

Page 44: Valerie d acremont

Methodology

• Prospective study including children attending two outpatient

clinics (one urban and one rural) in Tanzania

• Inclusion criteria:

- aged 2 months - 10 yrs

- temperature > 38°C

• Full clinical assessment and investigations

based on pre-defined algorithms

• Computer-based diagnosis with levels of probability

• Real-time (RT-)PCR of naso-pharyngeal swabs for 13 viruses

• PCR and serologies on blood ongoing

Page 45: Valerie d acremont

All ARI50%

4%

12%

1%

5%

3%

20%

1%

3%

10%

31%

All gastroenteritis9%

Acute Resp. Infect.

URTI

Bronchiolitis

Non-doc. pneumonia

Doc. pneumonia

Gastroenteritis

amoeba

Rota/Adenovirus

Salmonella/Shigella

unknown etiology

Urine infection

Skin infection

Other

Sepsis due tobacteriemia

TyphoidMalaria

Unknown

Results 1: etiologies in all patients

Page 46: Valerie d acremont

All ARI38%

All gastroenteritis8%

Acute Resp. Infect.

URTI

Bronchiolitis

Non-doc. pneumonia

Doc. pneumonia

Gastroenteritis

amoeba

Rota/Adenovirus

Salmonella/Shigella

unknown etiology

Urine infection

Skin infection

Other

Sepsis due tobacteriemia

TyphoidMalaria

Unknown

5%

20%

2% 4%

6%

10%

36%

2%

7%

Results 2: etiologies in severe patients

Page 47: Valerie d acremont

Results 3: proportion of children infected with viruses

0%

20%

40%

60%

80%

100%

severe

pneumoniapneumonia URTI

unknown

fever

other

disease

any virus

any virus except PIC

Kenyan study (same

viruses)

Ref: Berkley JAMA 2010

86% 87%

82% 80%

64%

WHO definition

‘control

group’

Page 48: Valerie d acremont

Results 6: seasonality of influenza

0%

10%

20%

30%

40%

50%

Apr May Jun Jul Aug

FLUAV

FLUBV

0%

10%

20%

30%

40%

50%

Jul Aug Sep Oct Nov

Dar es Salaam

Ifakara

Page 49: Valerie d acremont

Development of improved practice guidelines for clinicians

Modified IMCI including

1. laboratory tools : malaria test, urine dipstick

2. additional clinical criteria: predictors for bacterial infections

(Acute Resp. Infect., typhoid)

Emphasis on rationale use of drugs (antimalarials and antibiotics)

Fever study: beyond the findings

Page 50: Valerie d acremont

Development of improved practice guidelines for clinicians

Modified IMCI including

1. laboratory tools : malaria test, urine dipstick

2. additional clinical criteria: predictors for bacterial infections

(Acute Resp. Infect., typhoid)

Emphasis on rationale use of drugs (antimalarials and antibiotics)

Fever study: beyond the findings

The e-IMCI interface

Page 51: Valerie d acremont

Remerciements

DSM City Medical Office of Health, Tanzania

Judith Kahama (co-researcher)

Ndeniria Swai (research assistant)

Gerumana Mpawa (logistics and data entry)

Ministry of health and Welfare, Tanzania

Deo Mtasiwa (Chief Medical Officer)

Ifakara Health Institute, Tanzania

Hassan Mshinda (ex-director)

Amana and St Francis hospital, Tanzania

Willy Sangu and P. Kibatala (directors)

Swiss Tropical and Public Health Institute

Christian Lengeler & Blaise Genton

Hôpitaux Universitaires de Genève

Laurent Kaiser & Pascal Cherpillod

Support financier de la part du Fonds National de la Recherche Suisse

TDR fournis en grande partie par USAID/Tanzania sous President Malaria Initiative